# Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

> **NCT00296023** · NA · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 25 (actual)

## Conditions studied

- Chronic Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin
- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** therapeutic allogeneic lymphocytes
- **DRUG:** busulfan
- **DRUG:** fludarabine phosphate
- **DRUG:** methotrexate
- **DRUG:** tacrolimus
- **PROCEDURE:** nonmyeloablative allogeneic hematopoietic stem cell transplantation
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00296023
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-01
- **Primary completion:** 2007-06
- **Final completion:** 2008-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2012-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00296023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00296023, "Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00296023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*